(Q43198292)

English

Elevations of tumor necrosis factor receptor 1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

scientific article published on 11 January 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Elevations of tumor necrosis factor receptor 1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

author name string

E Willems

1

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

S Humblet-Baron

2

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

O Dengis

3

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

L Seidel

4

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Y Beguin

5

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

F Baron

6

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

language of work or name

0 references

publication date

11 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

45

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

1442-1448

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

https://scigraph.springernature.com/pub.10.1038/bmt.2009.360

0 references

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: current perspectives

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

What is the role for donor natural killer cells after nonmyeloablative conditioning?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Inflammation and bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Plasma elevations of tumor necrosis factor-receptor-1 at day 7 postallogeneic transplant correlate with graft-versus-host disease severity and overall survival in pediatric patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Mixed chimerism and transplant tolerance

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Graft-versus-host disease: how to translate new insights into new therapeutic strategies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of tumor necrosis factor-alpha in graft-versus-host disease and graft-versus-leukemia responses

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BMT.2009.360

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43198292&oldid=1983625388"